Kappa opioids inhibit spinal output neurons to suppress itch

Sci Adv. 2024 Sep 27;10(39):eadp6038. doi: 10.1126/sciadv.adp6038. Epub 2024 Sep 25.

Abstract

Itch is a protective sensation that drives scratching. Although specific cell types have been proposed to underlie itch, the neural basis for itch remains unclear. Here, we used two-photon Ca2+ imaging of the dorsal horn to visualize neuronal populations that are activated by itch-inducing agents. We identify a convergent population of spinal interneurons recruited by diverse itch-causing stimuli that represents a subset of neurons that express the gastrin-releasing peptide receptor (GRPR). Moreover, we find that itch is conveyed to the brain via GRPR-expressing spinal output neurons that target the lateral parabrachial nuclei. We then show that the kappa opioid receptor agonist nalfurafine relieves itch by selectively inhibiting GRPR spinoparabrachial neurons. These experiments provide a population-level view of the spinal neurons that respond to pruritic stimuli, pinpoint the output neurons that convey itch to the brain, and identify the cellular target of kappa opioid receptor agonists for the inhibition of itch.

MeSH terms

  • Animals
  • Interneurons / drug effects
  • Interneurons / metabolism
  • Male
  • Mice
  • Morphinans* / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism
  • Pruritus* / drug therapy
  • Pruritus* / metabolism
  • Receptors, Bombesin* / agonists
  • Receptors, Bombesin* / antagonists & inhibitors
  • Receptors, Bombesin* / metabolism
  • Receptors, Opioid, kappa* / agonists
  • Receptors, Opioid, kappa* / metabolism
  • Spinal Cord / drug effects
  • Spinal Cord / metabolism
  • Spiro Compounds / pharmacology

Substances

  • Receptors, Opioid, kappa
  • Receptors, Bombesin
  • Morphinans
  • TRK 820
  • Spiro Compounds